This might make companies worried, but it can also push them to improve their products
Phase 3 SURMOUNT trials demonstrated that 2.5 mg weekly tirzepatide produced mean weight loss of 5-7% over 68 weeks and significantly improved glycemic control in patients with obesity and type 2 diabetes
Shima Hadidchi, MD evaluates your health history, lifestyle, and goals to determine whether Semaglutide GLP-1 may be an appropriate option for your weight-loss plan
Therefore, in-depth analysis of the exact regulatory network of Bacteroidetes in the pathogenesis of OA through the gut-joint axis, and clarification of the functional specificity of different Bacteroides strains and their interactions with host metabolism, immune and inflammatory pathways, are of great theoretical and clinical significance for accurately understanding the mechanism of the influence of gut microbiota on OA and developing probiotic intervention strategies targeting specific strains
Designed for people with hypermobility and persistent pain, it focuses on how strength and stability are organised and learned by the nervous system, beginning with the feet and progressing through sensory input, coordination, and motor learning
Pharmacology & Toxicology, 88, 8188
